Exact Mass: 685.2921

Viomycin

C25H43N13O10 (685.3256)

A cyclic peptide antibiotic produced by the actinomycete Streptomyces puniceus, used in the treatment of tuberculosis. D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D000995 - Antitubercular Agents C254 - Anti-Infective Agent > C52588 - Antibacterial Agent > C280 - Antitubercular Agent D004791 - Enzyme Inhibitors > D011500 - Protein Synthesis Inhibitors

Rifamycin G

C36H47NO12 (685.3098)

Auramycin C

C35H43NO13 (685.2734)

Tuberactinomycin N

C25H43N13O10 (685.3256)

3,6-diamino-hexanoyl->-cyclo-[L-2,3-diamino-propionyl->-amino-(2-amino-6-hydroxy-1(3),4,5,6-tetrahydro-pyrimidin-4-yl)-acetyl->-L-seryl->-L-seryl->-2-amino-3-ureido-acryloyl-(1->N3)]|Viomycin

C25H43N13O10 (685.3256)

1-(N-methyl-L-phenylalanyl)-L-proline (4S)-7t-benzyl-5,8-dioxo-3t-phenyl-2-oxa-6,9-diaza-1(1,4)-benzena-cycloundecaphan-10c-en-4r-ylamide|Feretin|Feretine|N-demethyl-adouetine-Z

C41H43N5O5 (685.3264)

2,14-Diacetoxy-1-furoyloxydihydro-6-(2-methylbutanoyloxy)-9-nicotinoyloxy-beta-agarofuran

C35H43NO13 (685.2734)

Antibiotic CP 50833

C36H47NO10S (685.2921)

1alpha-nicotinoyloxy-2alpha-acetoxy-6beta-acetoxy-9beta-furoyloxy-11-(2-methyl)butyryloxy-4beta-hydroxydihydro-beta-agarofuran|2,6-Diacetoxy-9-furoyloxydihydro-14-(2-methylbutanoyloxy)-1-nicotinoyloxy-beta-agarofuran

C35H43NO13 (685.2734)

6-O-methyl-N-deacetyl-6-O-alpha-D-glucopyranosylisoipecosidic acid

C31H43NO16 (685.2582)

3beta-O-propionyl-5alpha,10beta,14beta-tri-O-acetyl-8beta-O-nicotinoylcyclomyrsinol|euphorbialoid G

C35H43NO13 (685.2734)

15beta-hydroxy-3beta-isobutanoyloxy-8alpha-nicotinyloxy-5alpha,7beta,9alpha-triacetyloxyjatropha-6(17),11E-diene-14-one|euphodendrophane M

C36H47NO12 (685.3098)

15beta-hydroxy-7beta-isobutanoyloxy-9alpha-nicotinyloxy-3beta,5alpha,8alpha-triacetyloxyjatropha-6(17),11E-diene-14-one|euphodendrophane N

C36H47NO12 (685.3098)

Antrimycin A|Cirratiomycin B

C28H47N9O11 (685.3395)

naphthomycin E

C40H47NO9 (685.3251)

20-episerpentinine

[C42H45N4O5]+ (685.339)

tBuXPhos Pd G1

C37H55ClNPPd (685.2795)

Enviomycin

C25H43N13O10 (685.3256)

D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D000995 - Antitubercular Agents C254 - Anti-Infective Agent > C258 - Antibiotic

5-({[4-(chloromethyl)phenyl]carbonyl}amino)-2-(1,2,2,4,8,10,10,11-octamethyl-10,11-dihydro-2H-pyrano[3,2-g:5,6-g]diquinolin-1-ium-6-yl)benzoate

C42H40ClN3O4 (685.2707)

(3S)-3,6-diamino-N-[(3S,6Z,9S,12S,15S)-3-[(4S)-2-amino-4-hydroxy-1,4,5,6-tetrahydropyrimidin-6-yl]-6-[(carbamoylamino)methylidene]-9,12-bis(hydroxymethyl)-2,5,8,11,14-pentaoxo-1,4,7,10,13-pentazacyclohexadec-15-yl]hexanamide

C25H43N13O10 (685.3256)

20-episerpentinine

C42H45N4O5+ (685.339)

CID 3037981

C25H43N13O10 (685.3256)

(3R,4R)-3,6-diamino-N-[(3S,9S,12S,15S)-3-[(4R)-2-amino-1,4,5,6-tetrahydropyrimidin-4-yl]-6-[(carbamoylamino)methylidene]-9,12-bis(hydroxymethyl)-2,5,8,11,14-pentaoxo-1,4,7,10,13-pentazacyclohexadec-15-yl]-4-hydroxyhexanamide

C25H43N13O10 (685.3256)

CellTracker red CMTPX 6-isomer

C42H40ClN3O4 (685.2707)

4,4,4-trifluoro-N-[[(3S,9S,10S)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-16-[(4-methylphenyl)sulfonylamino]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-N-methylbutanamide

C33H46F3N3O7S (685.3008)

N-(2-aminophenyl)-4-[[[(2S,3R)-9-(benzenesulfonamido)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl-methylamino]methyl]benzamide

C37H43N5O6S (685.2934)

4-fluoro-N-[(3S,9R,10R)-12-[(2S)-1-hydroxypropan-2-yl]-9-[[(4-methoxyphenyl)methyl-methylamino]methyl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]benzenesulfonamide

C36H48FN3O7S (685.3197)

N-(2-aminophenyl)-4-[[[(2R,3R)-9-(benzenesulfonamido)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl-methylamino]methyl]benzamide

C37H43N5O6S (685.2934)

4-fluoro-N-[(3S,9S,10S)-12-[(2R)-1-hydroxypropan-2-yl]-9-[[(4-methoxyphenyl)methyl-methylamino]methyl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]benzenesulfonamide

C36H48FN3O7S (685.3197)

8-[1-azocanyl(oxo)methyl]-6-[2-(2-hydroxyethoxy)phenyl]-3,4-diphenylspiro[1H-indole-3,7-4,6,8,8a-tetrahydro-3H-pyrrolo[2,1-c][1,4]oxazine]-1,2-dione

C42H43N3O6 (685.3152)

1-amino-N-[(5S,6R,7R,9R)-6-methoxy-5-methyl-14-oxo-6,7,8,9,15,16-hexahydro-5H,14H-5,9-epoxy-4b,9a,15-triazadibenzo[b,h]cyclonona[1,2,3,4-jkl]cyclopenta[e]-as-indacen-7-yl]-2,5,8,11-tetraoxatetradecan-14-amide

C37H43N5O8 (685.3111)

PS 18:2/9:4;O2

C33H52NO12P (685.3227)

PS 18:4/8:3;O3

C32H48NO13P (685.2863)

PS 20:3/7:3;O2

C33H52NO12P (685.3227)

PS 20:4/7:2;O2

C33H52NO12P (685.3227)

PS 22:5/5:1;O2

C33H52NO12P (685.3227)

PS 26:7;O3

C32H48NO13P (685.2863)

PS 27:6;O2

C33H52NO12P (685.3227)

Endomorphin 2 (TFA)

C34H38F3N5O7 (685.2723)

Endomorphin 2 TFA, a high affinity, highly selective agonist of the μ-opioid receptor, displays reasonable affinities for kappa3 binding sites, with Ki value between 20 and 30 nM[1]. Endomorphin 2 TFA, a high affinity, highly selective agonist of the μ-opioid receptor, displays reasonable affinities for kappa3 binding sites, with Ki value between 20 and 30 nM[1].

(1s,2s,4s,5r,6r,7s,9r,12r)-4,12-bis(acetyloxy)-7-(furan-3-carbonyloxy)-2-hydroxy-2,10,10-trimethyl-6-({[(2r)-2-methylbutanoyl]oxy}methyl)-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-5-yl pyridine-3-carboxylate

C35H43NO13 (685.2734)

(7e,9s,10s,11s,12e,14s,16e,20s,21s,22e,24z,26z)-4,10,14,20,28-pentahydroxy-3,7,9,11,17,21,27-heptamethyl-29-azatricyclo[28.3.1.0⁵,³³]tetratriaconta-1(33),2,4,7,12,16,22,24,26,28,30-undecaene-6,18,32,34-tetrone

C40H47NO9 (685.3251)

(2e)-n-[2-(3-chloro-4-methoxyphenyl)-1-{[2-methyl-2-(methyl-c-hydroxycarbonimidoyl)ethyl]-c-hydroxycarbonimidoyl}ethyl]-5-[(2-hydroxy-4-methylpentanoyl)oxy]-6-(3-phenyloxiran-2-yl)hept-2-enimidic acid

C36H48ClN3O8 (685.313)

1α-nicotinoyloxy-2α-acetoxy-6β-acetoxy-9β-furoyloxy-11-(2-methyl)butyryloxy-4β-hy-droxydihydro-β-agarofuran

C35H43NO13 (685.2734)

{"Ingredient_id": "HBIN002313","Ingredient_name": "1\u03b1-nicotinoyloxy-2\u03b1-acetoxy-6\u03b2-acetoxy-9\u03b2-furoyloxy-11-(2-methyl)butyryloxy-4\u03b2-hy-droxydihydro-\u03b2-agarofuran","Alias": "NA","Ingredient_formula": "C35H43NO13","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "15528","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

(7s,9e,11s,12r,13s,14r,15r,16r,17s,18s,19e,22r)-2,15,17-trihydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23,27-trioxo-8,29,30-trioxa-24-azatetracyclo[23.3.1.1⁴,⁷.0⁵,²⁸]triaconta-1,3,5(28),9,19,25-hexaen-13-yl acetate

C36H47NO12 (685.3098)

(3s,4r)-3,6-diamino-4-hydroxy-n-[(3s,6e,9r,12s,15s)-2,5,8,11,14-pentahydroxy-6-[(c-hydroxycarbonimidoylamino)methylidene]-9,12-bis(hydroxymethyl)-3-[(4s)-2-imino-1,3-diazinan-4-yl]-1,4,7,10,13-pentaazacyclohexadeca-1,4,7,10,13-pentaen-15-yl]hexanimidic acid

C25H43N13O10 (685.3256)

methyl (1r,2r,4s)-4-{[(2r,4s,6s)-5-{[(2s,4s,5s,6s)-4,5-dihydroxy-6-methyloxan-2-yl]oxy}-4-(dimethylamino)-6-methyloxan-2-yl]oxy}-2,5,7-trihydroxy-2-methyl-6,11-dioxo-3,4-dihydro-1h-tetracene-1-carboxylate

C35H43NO13 (685.2734)

4,12-bis(acetyloxy)-7-(furan-3-carbonyloxy)-2-hydroxy-2,10,10-trimethyl-6-{[(2-methylbutanoyl)oxy]methyl}-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-5-yl pyridine-3-carboxylate

C35H43NO13 (685.2734)

(4s,5r,6s)-5-ethenyl-4-{[(1s)-7-hydroxy-6-methoxy-1,2,3,4-tetrahydroisoquinolin-1-yl]methyl}-6-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-({[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}-5,6-dihydro-4h-pyran-3-carboxylic acid

C31H43NO16 (685.2582)

3,6-diamino-4-hydroxy-n-[(3r,6z)-2,5,8,11,14-pentahydroxy-6-[(c-hydroxycarbonimidoylamino)methylidene]-9,12-bis(hydroxymethyl)-3-(2-imino-1,3-diazinan-4-yl)-1,4,7,10,13-pentaazacyclohexadeca-1,4,7,10,13-pentaen-15-yl]hexanimidic acid

C25H43N13O10 (685.3256)

2,15,17-trihydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23,27-trioxo-8,29,30-trioxa-24-azatetracyclo[23.3.1.1⁴,⁷.0⁵,²⁸]triaconta-1,3,5(28),9,19,25-hexaen-13-yl acetate

C36H47NO12 (685.3098)

(1s,2r,3r,4s,5s,7r,8r,9r,10r,11s,12s,14r,15r)-2,8,12-tris(acetyloxy)-7-hydroxy-5,9,12-trimethyl-16-oxo-4-(propanoyloxy)-18-oxapentacyclo[7.7.2.0¹,¹⁰.0³,⁷.0¹¹,¹⁴]octadecan-15-yl pyridine-3-carboxylate

C35H43NO13 (685.2734)

5-ethenyl-4-[(7-hydroxy-6-methoxy-1,2,3,4-tetrahydroisoquinolin-1-yl)methyl]-6-{[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}-5,6-dihydro-4h-pyran-3-carboxylic acid

C31H43NO16 (685.2582)

methyl (1r,2r,4s)-4-{[(2s,4s,5r,6s)-5-{[(2s,4s,5s,6s)-4,5-dihydroxy-6-methyloxan-2-yl]oxy}-4-(dimethylamino)-6-methyloxan-2-yl]oxy}-2,5,7-trihydroxy-2-methyl-6,11-dioxo-3,4-dihydro-1h-tetracene-1-carboxylate

C35H43NO13 (685.2734)

(2s)-2-{[(2e)-2-{[(2s)-2-({[(3s)-2-[(2s,3s)-3-amino-2-{[(2s)-2-{[2-amino-1,3-dihydroxy-2-(hydroxymethyl)propylidene]amino}-1-hydroxypropylidene]amino}butanoyl]-4,5-dihydro-3h-pyridazin-3-yl](hydroxy)methylidene}amino)-1-hydroxypropylidene]amino}-1-hydroxy-3-methylpent-2-en-1-ylidene]amino}-3-hydroxypropanoic acid

C28H47N9O11 (685.3395)